Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
FSA & HSA
HSA and FSA accepted; no insurance needed.
Back

Weight Loss

14 min read

Ozempic babies: can prescription weight loss drugs boost fertility?

Sherry Christiansen

Written by Sherry Christiansen

Published: Aug 30, 2024

Medically Reviewed by Dr. Paul Hetrick

Share
Ozempic babies: can prescription weight loss drugs boost fertility?
Table of contents
Share

Ozempic (semaglutide) is a prescription drug in the GLP-1 receptor agonists class. It’s U.S Food and Drug Administration (FDA) approved to improve blood sugar and reduce the risk of serious cardiovascular events, including heart attack, stroke, and death in those with type 2 diabetes. People taking it lose weight, so it’s used off-label (for something it’s not prescribed for) for weight loss too. 

Taking it is also reportedly linked to unplanned pregnancies. Social media posts refer to this phenomenon as “Ozempic babies." But what’s reality and what’s hype? Do these weight loss drugs boost fertility and lead to pregnancy?

In this article, we dig in and offer some answers.

Is Ozempic right for you?

Get in with a provider in 24 hours or less and find out.*

Find a provider

If you’re struggling with obesity or are overweight, don’t wait to get the help, support, and weight loss treatment you deserve. Find a provider for a weight loss plan that may include Ozempic or another medication.

Overweight, obesity, and fertility and Ozempic babies

The American Society for Reproductive Medicine (ASRM) reported that obesity contributes to 6% of infertility cases in women who’ve never become pregnant. Women with a body mass index (BMI) between 24 and 31 are 30% more likely to have infertility problems linked with anovulation (when the ovary fails to release an egg during the menstrual cycle) than those at a healthy weight. When a person’s BMI is more than 31, that number increases to 170% more likely. 

Note: BMI measures a person’s body fat based on height and weight. Overweight is defined as a BMI greater than or equal to 25. A BMI greater than or equal to 30 is obesity.

How obesity and weight gain affect fertility

Several studies have shown that overweight and obesity affect reproductive functions in both men and women, resulting in lower fertility rates. Adverse reproductive effects of obesity and overweight can include:

  • Irregular menstrual cycles 
  • Impaired follicular (tiny fluid-filled sacs that contain one immature egg) development
  • Lower number of oocytes (eggs)
  • Poor quality of oocytes
  • Low sperm count or no sperm 
  • Impaired fertilization, embryo development, and implantation

The flip side of this may be that losing weight helps diminish or stop the effects that obesity and overweight have on fertility.

How PCOS may affect fertility

It’s estimated that 8 to 13% of women of reproductive age have polycystic ovary syndrome (PCOS). PCOS is a hormonal imbalance that may be caused by insulin resistance and other factors. It can cause infertility. And obesity can worsen its complications, including infertility. 

What are GLP-1 agonists?

A popular way to lose weight today is using glucagon-like peptide-1 (GLP-1) agonists — such as Ozempic or Wegovy (both semaglutide). Semaglutide lowers blood sugar by mimicking the actions of the GLP-1 hormone. The gut releases the GLP-1 hormone in response to eating, which increases insulin production and lowers blood sugar levels. 

In clinical trials and during post-marketing use, people taking Ozempic for diabetes also lost weight. And studies show that GLP-1 agonist medications lead to sometimes dramatic weight loss. One study found that people taking the 2-milligram Ozempic dose lost between 5% and sometimes more than 10% of their body weight in 40 weeks. People on the 2.4-milligram Wegovy dose lost an average of up to 14.9% of body weight in 68 weeks.

How weight loss and GLP-1s might improve fertility in women

Although researchers aren’t sure how, or if, weight loss and GLP-1 drugs, such as Ozempic and Wegovy, affect fertility, they have ideas, including that they:

  • Improve fertility by promoting weight loss as part of a weight loss program in previously infertile women
  • Make some types of birth control pills ineffective by interfering with their absorption (GLP-1 drugs slow stomach emptying, which impacts how food and drugs are absorbed)
  • Help regulate menstrual cycles and ovulation, which often occurs even with modest weight loss
  • Improve metabolic health which could restore healthy ovarian function

And because losing 5 to 10% of your body weight can improve both fertility and PCOS, losing weight with Ozempic might be responsible for Ozempic babies in women with and without PCOS and not Ozempic itself. 

How GLP-1 agonists may Improve fertility in men

While the exact mechanisms of how GLP-1 drugs work for weight loss aren’t well understood, several studies show that their use “appears to be involved in processes vital to spermatogenesis [sperm production].”

 A 2023 study showed an improvement in fertility rates when obese men took GLP-1 weight-loss drugs. The drugs were found to: 

  • Improve sperm motility (movement) and metabolism
  • Enhance insulin in vitro (in a lab Petry dish)
  • Promote positive effects on Sertoli cells ( testicular cells needed for sperm development)

Bottom line: Studies have yet to answer the question of Ozempic babies. But Ozempic itself probably isn’t resulting in Ozempic babies. Losing weight though may be making women and men who take it more fertile and likely to become (or contribute to becoming) pregnant. 

Birth control and Ozempic babies

The buzz over Ozempic babies may have you thinking about birth control. Are Ozempic babies the result of Ozempic affecting birth control? And can you take Ozempic and birth control

You can. And one study found that Ozempic did not interfere with the absorption of a certain type of oral contraceptives (birth control pills) that contain levonorgestrel and ethinyl estradiol. This study concluded that there was no evidence that Ozempic lowers the effectiveness of this type of contraceptive. There are many other types of birth control pills, so there’s not enough evidence to show whether Ozempic interferes with other types of contraceptives.

GLP-1 agonists, pregnancy, breastfeeding

Whether Ozempic leads to Ozempic babies or harms pregnant or breastfeeding women isn’t clear. 

People who were pregnant or planned to get pregnant were excluded from Ozempic’s initial clinical trials. And the FDA and Novo Nordisk, who makes Ozempic, couldn’t evaluate its safety during pregnancy. 

Since the drug’s FDA approval, preliminary studies implied that taking Ozempic or other GLP-1 medications during pregnancy may pose serious risks to a developing fetus. It was thought that the risks may include reduced fetal weight and growth or skeletal abnormalities of the developing fetus.

A more recent observational study published in JAMA Internal Medicine in February 2024 though found no apparent link between taking GLP-1 drugs early in pregnancy and major birth defects. 

Still, Novo Nordisk advises those who plan to become pregnant to stop taking Ozempic or Wegovy at least 2 months before trying to conceive. Women who become pregnant or are breastfeeding while taking Ozempic or Wegovy should immediately stop taking the medication.

Key takeaway on Ozempic babies

  • It’s possible that GLP-1 drugs like Ozempic affect fertility and are causing pregnancies, but the research hasn’t yet proven this.
  • Women are using social media platforms to announce getting pregnant after taking drugs like Ozempic and Wegovy. Many of these women had long-term infertility before taking GLP-1 medications. Others report getting pregnant while taking Ozempic despite being on birth control pills. 
  • Studies show that GLP-1 drugs may reduce the effectiveness of some types of birth control pills by interfering with their absorption.
  • There’s not enough available study data on whether GLP-1 drugs are safe during pregnancy. There are, though, animal studies that suggest they could harm a fetus during pregnancy. 
  • People are advised to stop taking drugs like Ozempic and Wegovy at least 2 months before trying to conceive. If they become pregnant while using these medications, they should stop taking them immediately.

Talk to a provider about Ozempic

If you want to lose weight and want to learn more about Ozempic and other alternatives, on Klarity, you can search providers and schedule an appointment to get the answers and information you need. Find a weight loss provider on Klarity today. 

Sources

ASRM, Obesity and Reproduction: A Committee Opinion, 2021, https://www.asrm.org/practice-guidance/practice-committee-documents/obesity-and-reproduction-a-committee-opinion-2021/

BMC Endocrine Disorders 23, Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review, 2023, https://doi.org/10.1186/s12902-023-01500-5 https://pubmed.ncbi.nlm.nih.gov/31260047/

Current Obesity Reports, Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over, Donna H. Ryan, MD, FTOS, and Sarah Ryan Yockey, MD, FACOG, Jun. 2018, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497590/

Front Endocrinol (Lausanne), Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence, Oct. 2023, https://pubmed.ncbi.nlm.nih.gov/37881498/

Human Reproduction, Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK, Christiane Lundegaard Haase, Anette Varbo, Peter Nørkjær Laursen, Volker Schnecke, and Adam H. Balen, Jan. 2023, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977115/

Human Reproduction Update, The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective, Jul. 2019, https://pubmed.ncbi.nlm.nih.gov/31260047/
Medicina, Impact of GLP-1 Agonists on Male Reproductive Health-A Narrative Review, Dec. 2023, https://www.doi.org/10.3390/medicina60010050

JAMA Internal Medicine, Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy, Cesta CE, Rotem R, Bateman BT, Chodick G, Cohen JM, Furu K, Gissler M, Huybrechts KF, Kjerpeseth LJ, Leinonen MK, Pazzagli L, Zoega H, Seely EW, Patorno E, Hernández-Díaz S., Feb. 2024, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714281/

JAMA Network Open, Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity, 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486455/ 

Journal of Clinical Pharmacology, Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel, 2015, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418331/ 

JP Morgan, The increase in appetite for obesity drugs, Nov, 2023, https://www.jpmorgan.com/insights/global-research/current-events/obesity-drugs

MDPI, Molecules, Peptides from natural or rationally designed sources can be used in
overweight, obesity, and type 2 diabetes therapies, 2020, https://doi.org/10.3390/molecules25051093 

New England Journal of Medicine, Once-weekly semaglutide in adults with overweight or obesity, 2021, https://www.nejm.org/doi/full/10.1056/NEJMoa2032183 

The Journal of the Turkish-German Gynecological Association. , Impact of obesity on infertility in women, Jun. 2015, https://doi.org/10.5152/jtgga.2015.15232 

The Lancet: Diabetes & Endocrinology, Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial, Juan P. Frias et. al., Jul. 2021, https://pubmed.ncbi.nlm.nih.gov/34293304/

World Health Organization (WHO), Obesity and Overweight, 2024, https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight 

World Health Organization, Polycystic ovary syndrome, Jun. 2023, https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome

Wegovy Prescribing Information. https://www.wegovy.com/tools-and-resources/faq.htm

How we reviewed this article

This article went through rigorous fact-checking by a team of medical reviewers. Reviewers are trained medical professionals who ensure each article contains the most up-to-date information, and that medical details have been correctly interpreted by the author. Learn more about the editorial and medical review process and standards for the HelloKlarity site.

*Appointments are generally available within 24 hours. Prescriptions, particularly for controlled substances, may require an in-person evaluation depending on the state of residence and current federal regulations.

The information provided in this article is for educational purposes only and should not be construed as medical advice. Always seek the guidance of a qualified healthcare professional with any questions or concerns you have regarding your health. Providers on Klarity Health are independent practitioners with clinical autonomy. Nothing in this article is intended to diagnose or treat any condition, including guaranteeing prescription medication of any kind or dosage. 

Get the latest health tips, insights, and advice from Klarity

Subscribe to the blog. No spam. Unsubscribe at any time.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide any medical services.
Fax:
(855) 975-3008

PO Box 5098 Redwood City, CA 94063

100 Broadway Street, Redwood City CA, 94063

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide any medical services.
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Hotline: Call 988. Crisis Text Line: Text Home to 741-741
Fax:
(855) 975-3008

PO Box 5098 Redwood City, CA 94063

100 Broadway Street, Redwood City CA, 94063

If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Hotline: Call 988. Crisis Text Line: Text Home to 741-741
© 2024 Klarity Health, Inc. All rights reserved.